MiR-26b-3p Promotes Intestinal Motility Disorder by Targeting FZD10 to Inhibit GSK3 β/β-Catenin Signaling and Induce Enteric Glial Cell Apoptosis
In conclusion, this study indicated that miR-26b-3p promotes intestinal motility disorders by targeting FZD10 to block GSK3β/β-catenin signaling and induces apoptosis in EGCs. Our results provide a new research target for the treatment and intervention of intestinal dysmoti lity.
Source: Molecular Neurobiology - Category: Neurology Source Type: research
More News: Brain | Constipation | Dysmotility | Gastroenterology | Genetics | Imodium | Loperamide | Neurology | Study